159 related articles for article (PubMed ID: 26630394)
1. Association between the serotonin transporter and cytokines: Implications for the pathophysiology of bipolar disorder.
Chou YH; Hsieh WC; Chen LC; Lirng JF; Wang SJ
J Affect Disord; 2016 Feb; 191():29-35. PubMed ID: 26630394
[TBL] [Abstract][Full Text] [Related]
2. Neither cortisol nor brain-derived neurotrophic factor is associated with serotonin transporter in bipolar disorder.
Chou YH; Lirng JF; Hsieh WC; Chiu YC; Tu YA; Wang SJ
Eur Neuropsychopharmacol; 2016 Feb; 26(2):280-287. PubMed ID: 26706694
[TBL] [Abstract][Full Text] [Related]
3. Association of thalamic serotonin transporter and interleukin-10 in bipolar I disorder: a SPECT study.
Hsu JW; Lirng JF; Wang SJ; Lin CL; Yang KC; Liao MH; Chou YH
Bipolar Disord; 2014 May; 16(3):241-8. PubMed ID: 24372850
[TBL] [Abstract][Full Text] [Related]
4. Decreased brain serotonin transporter binding in the euthymic state of bipolar I but not bipolar II disorder: a SPECT study.
Chou YH; Wang SJ; Lin CL; Mao WC; Lee SM; Liao MH
Bipolar Disord; 2010 May; 12(3):312-8. PubMed ID: 20565438
[TBL] [Abstract][Full Text] [Related]
5. Aggression in bipolar II disorder and its relation to the serotonin transporter.
Chou YH; Lin CL; Wang SJ; Lirng JF; Yang KC; Chien Chang A; Liao MH
J Affect Disord; 2013 May; 147(1-3):59-63. PubMed ID: 23123132
[TBL] [Abstract][Full Text] [Related]
6. Probing the Serotonin Transporter Availability Among Male Cigarette Smokers: A SPECT Study With [123I] ADAM.
Zhao RJ; Lin SH; Lee LT; Lee IH; Chen PS; Chen KC; Yang YK
J Addict Med; 2016; 10(2):89-92. PubMed ID: 26742023
[TBL] [Abstract][Full Text] [Related]
7. Impaired cognition in bipolar I disorder: the roles of the serotonin transporter and brain-derived neurotrophic factor.
Chou YH; Wang SJ; Lirng JF; Lin CL; Yang KC; Chen CK; Yeh CB; Liao MH
J Affect Disord; 2012 Dec; 143(1-3):131-7. PubMed ID: 22889524
[TBL] [Abstract][Full Text] [Related]
8. Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study.
Catafau AM; Perez V; Plaza P; Pascual JC; Bullich S; Suarez M; Penengo MM; Corripio I; Puigdemont D; Danus M; Perich J; Alvarez E
Psychopharmacology (Berl); 2006 Dec; 189(2):145-53. PubMed ID: 17033844
[TBL] [Abstract][Full Text] [Related]
9. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study.
Newberg AB; Amsterdam JD; Wintering N; Ploessl K; Swanson RL; Shults J; Alavi A
J Nucl Med; 2005 Jun; 46(6):973-7. PubMed ID: 15937308
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 family and serotonin transporter in first-episode, drug-naive major depressive disorder: A pilot study.
Yang KC; Liu MN; Liou YJ; Hu LY; Yang BH; Chou YH
J Psychiatr Res; 2021 Mar; 135():174-180. PubMed ID: 33493946
[TBL] [Abstract][Full Text] [Related]
11. Quantifying midbrain serotonin transporter in depression: a preliminary study of diagnosis and naturalistic treatment outcome.
Tsai HC; Lin SH; Chen PS; Chang HH; Lee IH; Yeh TL; Chen KC; Chiu NT; Yao WJ; Liao MH; Yang YK
Pharmacopsychiatry; 2015 Mar; 48(2):58-64. PubMed ID: 25626060
[TBL] [Abstract][Full Text] [Related]
12. Brain SPECT imaging and whole-body biodistribution with [(123)I]ADAM - a serotonin transporter radiotracer in healthy human subjects.
Lin KJ; Liu CY; Wey SP; Hsiao IT; Wu J; Fu YK; Yen TC
Nucl Med Biol; 2006 Feb; 33(2):193-202. PubMed ID: 16546673
[TBL] [Abstract][Full Text] [Related]
13. Brain and platelet serotonin transporter in humans-correlation between [123I]-ADAM SPECT and serotonergic measurements in platelets.
Uebelhack R; Franke L; Herold N; Plotkin M; Amthauer H; Felix R
Neurosci Lett; 2006 Oct; 406(3):153-8. PubMed ID: 16934400
[TBL] [Abstract][Full Text] [Related]
14. Association between serotonin transporter availability and hostility scores in healthy volunteers - a single photon emission computed tomography study with [(123)I] ADAM.
Yang YK; Yao WJ; Yeh TL; Lee IH; Chen KC; Lu RB
Psychiatry Res; 2007 Apr; 154(3):281-4. PubMed ID: 17349781
[TBL] [Abstract][Full Text] [Related]
15. Which demographic variables are necessary to correct in neuroimaging studies of serotonin transporter availability? A SPECT study with [¹²³I]ADAM.
Chang WH; Lee LT; Lee IH; Chi MH; Chen KC; Chiu NT; Yao WJ; Chen PS; Yang YK
Psychiatry Res; 2015 Mar; 231(3):320-4. PubMed ID: 25670644
[TBL] [Abstract][Full Text] [Related]
16. Comparison of brain serotonin transporter using [I-123]-ADAM between obese and non-obese young adults without an eating disorder.
Wu CH; Chang CS; Yang YK; Shen LH; Yao WJ
PLoS One; 2017; 12(2):e0170886. PubMed ID: 28182708
[TBL] [Abstract][Full Text] [Related]
17. Lower availability of midbrain serotonin transporter between healthy subjects with and without a family history of major depressive disorder - a preliminary two-ligand SPECT study.
Hsieh PC; Chen KC; Yeh TL; Lee IH; Chen PS; Yao WJ; Chiu NT; Chen CC; Liao MH; Yang YK
Eur Psychiatry; 2014 Sep; 29(7):414-8. PubMed ID: 24439516
[TBL] [Abstract][Full Text] [Related]
18. No seasonal variation in human midbrain serotonin transporter availability in Taiwan.
Cheng YS; Chen KC; Yang YK; Chen PS; Yeh TL; Lee IH; Chang YH; Liao MH
Psychiatry Res; 2011 Dec; 194(3):396-399. PubMed ID: 22041533
[TBL] [Abstract][Full Text] [Related]
19. Association between the dexamethasone suppression test and serotonin transporter availability in healthy volunteer: a SPECT with [(123)I] ADAM study.
Tsai HY; Lee IH; Yeh TL; Yao WJ; Chen KC; Chen PS; Chiu NT; Lu RB; Yang YK
Eur Neuropsychopharmacol; 2012 Sep; 22(9):641-6. PubMed ID: 22356823
[TBL] [Abstract][Full Text] [Related]
20. Binding kinetics of 123I[ADAM] in healthy controls: a selective SERT radioligand.
Sacher J; Asenbaum S; Klein N; Geiss-Granadia T; Mossaheb N; Poetzi C; Attarbaschi T; Lanzenberger R; Spindelegger C; Rabas A; Heinze G; Dudczak R; Kasper S; Tauscher J
Int J Neuropsychopharmacol; 2007 Apr; 10(2):211-8. PubMed ID: 16487452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
